Infection and atherosclerosis: emerging mechanistic paradigms
- PMID: 10421626
- DOI: 10.1161/01.cir.100.4.e20
Infection and atherosclerosis: emerging mechanistic paradigms
Abstract
Although definitive proof of a causal role of infection contributing to atherogenesis is lacking, multiple investigations have demonstrated that infectious agents evoke cellular and molecular changes supportive of such a role. Moreover, both Chlamydia pneumoniae and cytomegalovirus exacerbate lesion development in animal models of atherosclerosis and restenosis. The fact that multiple pathogens have been associated with atherosclerosis implies that many "atherogenic" pathogens exist, and recent data suggest that the risk of atherosclerosis conveyed by infection relates to the number of atherogenic pathogens with which an individual is infected. It also is evident that variability in host susceptibility to the atherogenic effects of pathogens exists; this variability appears to be related at least in part to whether the host can generate an immune response that successfully controls pathogen inflammatory activity and in part to the specific pattern of immune response--humoral or cellular. The latter may relate to host capacity to control pathogen activity and to a pathogen-induced autoimmune component of the atherogenic process. Additional animal and human studies are necessary to further test the validity of the infection/atherosclerosis link and to provide more insight into the mechanisms by which infection may contribute to atherosclerosis, information critical for devising strategies to reduce or eliminate any contribution to atherosclerosis caused by infection.
Similar articles
-
Potential infectious etiologies of atherosclerosis: a multifactorial perspective.Emerg Infect Dis. 2001 Sep-Oct;7(5):780-8. doi: 10.3201/eid0705.010503. Emerg Infect Dis. 2001. PMID: 11747688 Free PMC article. Review.
-
Atherosclerosis and infection due to Chlamydia pneumoniae or cytomegalovirus: weighing the evidence.Clin Infect Dis. 1999 Apr;28(4):746-9. doi: 10.1086/515216. Clin Infect Dis. 1999. PMID: 10825031 Review.
-
[Chlamydia pneumoniae and atherosclerosis].Ugeskr Laeger. 1997 Sep 8;159(37):5503-7. Ugeskr Laeger. 1997. PMID: 9312918 Review. Danish.
-
Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.J Infect Dis. 2000 Jun;181 Suppl 3:S402-10. doi: 10.1086/315596. J Infect Dis. 2000. PMID: 10839724 Review.
-
Infection and atherosclerosis--focus on cytomegalovirus and Chlamydia pneumoniae.Ann Pharmacother. 1998 Dec;32(12):1310-6. doi: 10.1345/aph.18057. Ann Pharmacother. 1998. PMID: 9876813 Review.
Cited by
-
Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease.BMC Cardiovasc Disord. 2005 May 20;5(1):10. doi: 10.1186/1471-2261-5-10. BMC Cardiovasc Disord. 2005. PMID: 15943888 Free PMC article.
-
High prevalence of human cytomegalovirus in carotid atherosclerotic plaques obtained from Russian patients undergoing carotid endarterectomy.Herpesviridae. 2013 Nov 14;4(1):3. doi: 10.1186/2042-4280-4-3. Herpesviridae. 2013. PMID: 24229441 Free PMC article.
-
Influenza virus infection and risk of acute myocardial infarction.Inflammation. 2008 Aug;31(4):266-72. doi: 10.1007/s10753-008-9074-2. Inflammation. 2008. PMID: 18568394
-
Current Helicobacter pylori infection is significantly associated with subclinical coronary atherosclerosis in healthy subjects: A cross-sectional study.PLoS One. 2018 Mar 2;13(3):e0193646. doi: 10.1371/journal.pone.0193646. eCollection 2018. PLoS One. 2018. PMID: 29499055 Free PMC article.
-
Characterization of a natural mouse monoclonal antibody recognizing epitopes shared by oxidized low-density lipoprotein and chaperonin 60 of Aggregatibacter actinomycetemcomitans.Immunol Res. 2016 Jun;64(3):699-710. doi: 10.1007/s12026-015-8781-7. Immunol Res. 2016. PMID: 26786003
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical